RPA1 and COVID-19: Recent study has highlighted the turnaround of COVID-19 diagnosis (Larremore et al., 2021) and several studies have revealed the feasibility of reducing the incubation time for RT-RPA and Cas12a reactions (Qing et al., 2020; Park et al., 2021; Zhang et al., 2021).